Showing results (1041-1050 of 5,692) with videos related to
Sort By:
Pageof 570
The Oncologist|January 28, 2017
Mixed Responses to Systemic Therapy Revealed Potential Genetic Heterogeneity and Poor Survival in Patients with Non-Small Cell Lung CancerZhong-Yi Dong, Hao-Ran Zhai, Qing-Yi Hou, et al.The Oncologist|March 22, 2019
Ovarian Cancer Maintenance: Practice-Changing Data Calls for Changing PracticeLeslie M Randall, Michael J Birrer, Thomas J HerzogThe Oncologist|March 24, 2019
Cutaneous Toxicity After Chemoradiotherapy and PD-L1 Inhibition in Two Patients with Esophageal Adenocarcinoma: More than Meets the EyeTom van den Ende, Stef P Menting, Carmen A Ambarus, et al.The Oncologist|March 24, 2019
Anlotinib Versus Sunitinib as First-Line Treatment for Metastatic Renal Cell Carcinoma: A Randomized Phase II Clinical TrialAi-Ping Zhou, Yuxian Bai, Yan Song, et al.The Oncologist|April 15, 2017
Data Linkage to Improve Geriatric Oncology Research: A Feasibility StudyJennifer L Lund, Anne-Marie Meyer, Allison M Deal, et al.The Oncologist|March 23, 2019
Accelerated Risk of Premature Ischemic Stroke in 5-Year Survivors of Nasopharyngeal CarcinomaMin-Chi Chen, Feng-Che Kuan, Shiang-Fu Huang, et al.The Oncologist|April 5, 2019
Exploring Patient Decision Making Regarding Discontinuation of Tyrosine Kinase Inhibitors for Chronic Myeloid LeukemiaKathryn E Flynn, Judith M Myers, Anita D'Souza, et al.The Oncologist|July 19, 2019
Role of Resection Following Focal Progression with Standard Doses of Imatinib in Patients with Advanced Gastrointestinal Stromal Tumors: Results of Propensity Score AnalysesHyungwoo Cho, Min-Hee Ryu, Yongjune Lee, et al.The Oncologist|January 1, 2008
Hepatocellular carcinoma: the role of the North American GI Steering Committee Hepatobiliary Task Force and the advent of effective drug therapyBert H O'Neil, Alan P VenookPageof 570